|
Mar 26
|
Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives
|
|
Mar 26
|
FDA approves Merck lung disease drug acquired in $11B deal
|
|
Mar 26
|
Merck Foundation Strengthens Its Commitment to Expanding Access to Care in Asia-Pacific Region
|
|
Mar 26
|
20 Biggest Health Care Companies in Australia, 2024
|
|
Mar 25
|
Is Merck (NYSE:MRK) A Risky Investment?
|
|
Mar 24
|
16 Most Undervalued Growth Stocks To Buy According To Hedge Funds
|
|
Mar 22
|
Merck (MRK) Gains As Market Dips: What You Should Know
|
|
Mar 22
|
Merck's (MRK) Keytruda-Lynparza Combo Fails 2nd Lung Cancer Study
|
|
Mar 21
|
New Blood Thinners Will Prevent Blood Clots Without Causing Bleeding
|
|
Mar 21
|
11 Best Healthcare ETFs To Buy Now
|
|
Mar 21
|
The Zacks Analyst Blog Highlights JPMorgan Chase, Merck, SAP, Lam Research and Brown-Forman
|
|
Mar 21
|
Merck Provides Update on Phase 3 KEYLYNK-006 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Maintenance LYNPARZA® (olaparib) for Certain Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer
|
|
Mar 20
|
Top Research Reports for JPMorgan Chase, Merck & SAP
|
|
Mar 20
|
Merck & Co., Inc. (NYSE:MRK) is largely controlled by institutional shareholders who own 78% of the company
|
|
Mar 19
|
Merck Announces Positive Data on V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults, Demonstrated Immune Responses in Adults
|
|
Mar 16
|
Insiders At Merck Sold US$15m In Stock, Alluding To Potential Weakness
|
|
Mar 15
|
FarmSee Ltd Announces the Completion of a Minority Investment in its Swine Monitoring Platform
|
|
Mar 15
|
20 States with the Highest Cancer Rates
|
|
Mar 15
|
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy (CRT) Significantly Improved Overall Survival (OS) Versus CRT Alone in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer
|
|
Mar 14
|
Merck (MRK) Falls More Steeply Than Broader Market: What Investors Need to Know
|